Julie Boucquemont1, Lucie Loubère1, Marie Metzger2, Christian Combe3,4, Bénédicte Stengel2, Karen Leffondre1. 1. Univ. Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health Research, Bordeaux, France. 2. CESP, Inserm, Univ Paris-Sud, UVSQ, Univ Paris-Saclay, Villejuif, France. 3. Centre Hospitalier Universitaire de Bordeaux, Service de Néphrologie Transplantation Dialyse, Bordeaux, France. 4. Unité INSERM 1026, University of Bordeaux, Bordeaux, France.
Abstract
Background: Renal function in patients with chronic kidney disease (CKD) may follow different trajectory profiles. The aim of this study was to evaluate and illustrate the ability of the latent class linear mixed model (LCMM) to identify clinically relevant subgroups of renal function trajectories within a multicenter hospital-based cohort of CKD patients. Methods: We analysed data from the NephroTest cohort including 1967 patients with all-stage CKD at baseline who had glomerular filtration rate (GFR) both measured by 51 Cr-EDTA renal clearance (mGFR) and estimated by the CKD-EPI equation (eGFR); 1103 patients had at least two measurements. The LCMM was used to identify subgroups of GFR trajectories, and patients' characteristics at baseline were compared between the subgroups identified. Results: Five classes of mGFR trajectories were identified. Three had a slow linear decline of mGFR over time at different levels. In the two others, patients had a high level of mGFR at baseline with either a strong nonlinear decline over time ( n = 11) or a nonlinear improvement ( n = 94) of mGFR. Higher levels of proteinuria and blood pressure at baseline were observed in classes with either severely decreased mGFR or strong mGFR decline over time. Using eGFR provided similar findings. Conclusion: The LCMM allowed us to identify in our cohort five clinically relevant subgroups of renal function trajectories. It could be used in other CKD cohorts to better characterize their different profiles of disease progression, as well as to investigate specific risk factors associated with each profile.
Background: Renal function in patients with chronic kidney disease (CKD) may follow different trajectory profiles. The aim of this study was to evaluate and illustrate the ability of the latent class linear mixed model (LCMM) to identify clinically relevant subgroups of renal function trajectories within a multicenter hospital-based cohort of CKD patients. Methods: We analysed data from the NephroTest cohort including 1967 patients with all-stage CKD at baseline who had glomerular filtration rate (GFR) both measured by 51 Cr-EDTA renal clearance (mGFR) and estimated by the CKD-EPI equation (eGFR); 1103 patients had at least two measurements. The LCMM was used to identify subgroups of GFR trajectories, and patients' characteristics at baseline were compared between the subgroups identified. Results: Five classes of mGFR trajectories were identified. Three had a slow linear decline of mGFR over time at different levels. In the two others, patients had a high level of mGFR at baseline with either a strong nonlinear decline over time ( n = 11) or a nonlinear improvement ( n = 94) of mGFR. Higher levels of proteinuria and blood pressure at baseline were observed in classes with either severely decreased mGFR or strong mGFR decline over time. Using eGFR provided similar findings. Conclusion: The LCMM allowed us to identify in our cohort five clinically relevant subgroups of renal function trajectories. It could be used in other CKD cohorts to better characterize their different profiles of disease progression, as well as to investigate specific risk factors associated with each profile.
Authors: Marvin Gonzalez-Quiroz; Evangelia-Theano Smpokou; Richard J Silverwood; Armando Camacho; Dorien Faber; Brenda La Rosa Garcia; Amin Oomatia; Michael Hill; Jason Glaser; Jennifer Le Blond; Catharina Wesseling; Aurora Aragon; Liam Smeeth; Neil Pearce; Dorothea Nitsch; Ben Caplin Journal: J Am Soc Nephrol Date: 2018-06-15 Impact factor: 10.121
Authors: Jan A J G van den Brand; Tjeerd M H Dijkstra; Jack Wetzels; Bénédicte Stengel; Marie Metzger; Peter J Blankestijn; Hiddo J Lambers Heerspink; Ron T Gansevoort Journal: PLoS One Date: 2019-05-09 Impact factor: 3.240
Authors: Elisabet Van Loon; Wanqiu Zhang; Maarten Coemans; Maarten De Vos; Marie-Paule Emonds; Irina Scheffner; Wilfried Gwinner; Dirk Kuypers; Aleksandar Senev; Claire Tinel; Amaryllis H Van Craenenbroeck; Bart De Moor; Maarten Naesens Journal: JAMA Netw Open Date: 2021-12-01
Authors: Abigail R Smith; Jarcy Zee; Nan Ji; Jonathan P Troost; Brenda W Gillespie; Viji Nair; Qian Liu; Keisha L Gibson; Matthias Kretzler; Laura H Mariani Journal: Kidney Med Date: 2020-06-05